Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve the unaudited standalone & consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Ltd has informed BSE that its Board of Directors will meet on Thursday, 12 February 2026 at its Delhi office. The key agenda item is to consider and approve the unaudited standalone and consolidated financial results for the third quarter ended 31 December 2025. Any other business matters may also be taken up with the Chair's permission. The trading window for designated persons has already been closed since 1 January 2026 and will reopen 48 hours after the results are declared. This is a standard regulatory intimation under SEBI LODR Regulations, 2015.
No direct impact on shareholders at this stage. Investors should watch for the actual Q3 results on or shortly after 12 February 2026 to gauge the company's financial performance. The closed trading window signals insider-restricted activity until results are published.